Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo

Journal of Endocrinological Investigation

Volumn 24, Issue 6, 2001, Pages 430-437

  Nielsen, Steen ^a   Mellemkjaer S ^a   Rasmussen, L M ^a   Ledet, T ^a   Olsen, N ^a   Bojsen Moller M ^a   Astrup, J ^a   Weeke, J ^a   Jorgensen J O L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

GnRH receptors; Pituitary adenomas; Somatostatin receptors

Indexed keywords

ANTIHYPERTENSIVE AGENT; BROMOCRIPTINE; DESMOPRESSIN; ESTRADIOL; GONADORELIN RECEPTOR; GROWTH HORMONE; HYDROCORTISONE; INSULIN; LISINOPRIL; MESSENGER RNA; NORETHISTERONE; OCTREOTIDE; SOMATOSTATIN RECEPTOR; TESTOSTERONE; THYROXINE;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CUSHING DISEASE; FEMALE; GENE EXPRESSION; HORMONE ACTION; HORMONE RECEPTOR TRANSLOCATION; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; IN VIVO STUDY; MALE; MOLECULAR BIOLOGY; PREOPERATIVE EVALUATION; PROLACTINOMA; RECEPTOR AFFINITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCINTIGRAPHY; TRANSSPHENOIDAL HYPOPHYSECTOMY; TUMOR BIOPSY; TUMOR VOLUME;

ACROMEGALY; ADENOMA; ADULT; AGED; BIOPSY; CUSHING SYNDROME; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PROLACTINOMA; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0034971447     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03351043     Document Type: Article

References (27)

1. Chronic somatostatin analog administration in patients with alpha-subunit-secreting pituitary tumors
2. Somatostatin receptor imaging in somatotroph and non-functioning pituitary adenomas: Correlation with hormonal and visual responses to octreotide
3. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors
4. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: Effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy
5. Somatostatin receptor scintigraphy in patients with pituitary adenoma Somatostatin receptor scintigraphy in patients with pituitary adenoma
6. Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation
7. Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors
8. Expression of three somatostatin receptor subtypes in pituitary adenomas: Evidence for preferential SSTR5 expression in the mammosomatotroph lineage
9. Somatostatin receptor subtype gene expression in pituitary adenomas
10. Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors
11. Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitro
12. Quantitative and functional expression of somatostatin receptor subtypes in human prolactinomas
13. Human somatostatin receptor subtypes in acromegaly: Distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes
14. The World Health Organization classification of adenohypophysial neoplasms. A proposed five-tier scheme
15. Extensive personal experience: Gonadotroph adenomas
16. Gonadotropin-releasing hormone receptor mRNA expression by human pituitary tumors in vitro
17. Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitro
18. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: The Rotterdam experience with more than 1000 patients
19. Somatostatin receptor imaging in non-functioning pituitary adenomas: Value of an uptake index
20. Somatostatin receptor imaging in CNS tumours using 111In-octreotide
21. Immunocytochemistry of pituitary tumors
22. Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: Evidence for different tumor subclasses
23. Somatostatin receptors and disease: Role of receptor subtypes
24. Results of somatostatin receptor scintigraphy do not predict pituitary tumor volume- and hormone-response to octreotide therapy and do not correlate with tumor histology
25. Somatostatin receptor scintigraphy in pituitary adenomas: A somatostatin receptor density index can predict hormonal and tumoral efficacy of octreotide in vivo
26. Gonadotrophin-releasing hormone messenger RNA expression in gonadotroph tumors and normal human pituitary
27. Gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor messenger ribonucleic acids expression in nontumorous and neoplastic pituitaries